Edition:
India

Carl O'Donnell

Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.

Twitter handle: @jeffmason1

10 Jan 2018

U.S. pharma executives expect deals to pick up after tax overhaul

SAN FRANCISCO The Trump administration's tax overhaul should accelerate major acquisitions by drugmakers in 2018 after a slow year for deals in 2017, according to senior executives from some of the largest pharmaceutical manufacturers.

22 Dec 2017

Exclusive: U.S. cancer drugmaker Ignyta in advanced sale talks - sources

Ignyta Inc is in advanced talks to sell itself, people familiar with the matter said on Thursday, just three years after the U.S. cancer drugmaker became a public company focused on precision drugs and diagnostics.

21 Dec 2017

Snow Park to challenge Altisource Residential's board-sources

Dec 21 Activist hedge fund Snow Park Capital Partners LP is preparing a slate to replace directors on the board of residential real estate investment trust (REIT) Altisource Residential Corp., people familiar with the matter said on Thursday.

11 Dec 2017

Exclusive: U.S. mall owner GGP rejects Brookfield Property's $14.8 billion offer - sources

NEW YORK GGP Inc , one of the largest owners and operators of U.S. shopping centers, has rejected a $14.8 billion buyout offer from its biggest shareholder, Brookfield Property Partners LP , people familiar with the matter said on Sunday.

07 Dec 2017

Exactech gets higher $737 million cash offer from TPG Capital

(The Dec. 4 story corrects paragraph 5 to show that Exactech will not be pursuing a wholesale transition of its distributor model)

04 Dec 2017

CVS Health to acquire Aetna for $69 billion in year's largest acquisition

U.S. drugstore chain operator CVS Health Corp said on Sunday it had agreed to acquire U.S. health insurer Aetna Inc for $69 billion, seeking to tackle soaring healthcare spending through lower-cost medical services in pharmacies. | Video

03 Dec 2017

Aetna's board set to approve $68 bln sale to CVS Health -sources

Dec 3 Aetna Inc's board of directors was meeting on Sunday to approve the U.S. health insurer's sale to U.S. drugstore chain operator CVS Health Corp for approximately $207 per share in cash and stock, according to people familiar with the matter.

02 Dec 2017

Exclusive: CVS eyes major expansion of health clinics with Aetna deal - sources

NEW YORK CVS Health Corp is planning to significantly expand health services at its retail pharmacies if it completes a more than $66 billion deal for insurer Aetna Inc , a move that could save more than $1 billion annually, people familiar with the matter said.

02 Dec 2017

Mednax fielding takeover interest from buyout firms: sources

Mednax Inc, a U.S. healthcare network operator targeted by activist hedge fund Elliott Management Corp, is fielding acquisition interest from several private equity firms, according to people familiar with the matter.

01 Dec 2017

CVS closes in on deal to buy health insurer Aetna: source

CVS Health Corp is moving closer to a more than $66 billion cash and stock deal to buy health insurer Aetna Inc that could be announced as early as Monday, a source familiar with the matter said on Thursday.

Markets

  • Asia
  • U.S.
  • Europe
  • Sectors
Stock Search
Sensex 35,798.01 + 286.43 +0.81%
Nikkei 23,816.33 + 8.27 +0.03%
Hang Seng 32,393.41 + 138.52 +0.43%
EUR/INR 78.288 +0.01%
USD/INR 63.820 +0.00%
GBP/INR 88.652 +0.19%
Gold 1,331.90 +0.00 +0.00%
Oil 63.92 +0.35 +0.55%
Corn 351.00 -1.00 -0.28%